Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Nasdaq Real Time Price USD

Cencora, Inc. (COR)

Compare
279.51
+2.10
+(0.76%)
At close: 4:00:02 PM EDT
275.00
-4.51
(-1.61%)
After hours: 5:34:15 PM EDT
Loading Chart for COR
  • Previous Close 277.41
  • Open 277.09
  • Bid 273.11 x 800
  • Ask 280.01 x 1400
  • Day's Range 276.44 - 279.80
  • 52 Week Range 214.77 - 280.70
  • Volume 1,406,018
  • Avg. Volume 1,605,053
  • Market Cap (intraday) 54.145B
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) 39.65
  • EPS (TTM) 7.05
  • Earnings Date May 7, 2025
  • Forward Dividend & Yield 2.20 (0.79%)
  • Ex-Dividend Date Feb 14, 2025
  • 1y Target Est 282.16

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

www.cencora.com

46,000

Full Time Employees

September 30

Fiscal Year Ends

Recent News: COR

View More

Performance Overview: COR

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

COR
24.68%
S&P 500 (^GSPC)
3.58%

1-Year Return

COR
16.02%
S&P 500 (^GSPC)
8.94%

3-Year Return

COR
84.29%
S&P 500 (^GSPC)
24.75%

5-Year Return

COR
254.91%
S&P 500 (^GSPC)
124.42%

Compare To: COR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: COR

View More

Valuation Measures

Annual
As of 4/1/2025
  • Market Cap

    53.74B

  • Enterprise Value

    58.66B

  • Trailing P/E

    39.35

  • Forward P/E

    18.08

  • PEG Ratio (5yr expected)

    1.07

  • Price/Sales (ttm)

    0.18

  • Price/Book (mrq)

    237.17

  • Enterprise Value/Revenue

    0.19

  • Enterprise Value/EBITDA

    18.25

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.46%

  • Return on Assets (ttm)

    2.86%

  • Return on Equity (ttm)

    198.15%

  • Revenue (ttm)

    303.19B

  • Net Income Avi to Common (ttm)

    1.4B

  • Diluted EPS (ttm)

    7.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.22B

  • Total Debt/Equity (mrq)

    2,689.43%

  • Levered Free Cash Flow (ttm)

    -164.15M

Research Analysis: COR

View More

Company Insights: COR

Research Reports: COR

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.